DeMaria T F, Apicella M A, Nichols W A, Leake E R
The Ohio State University, Columbus 43210, USA.
Infect Immun. 1997 Nov;65(11):4431-5. doi: 10.1128/iai.65.11.4431-4435.1997.
Considerable evidence has implicated nontypeable Haemophilus influenzae (NTHi) lipooligosaccharide (LOS) in the pathogenesis of otitis media (OM); however, its exact role has not been conclusively established. Recently, two NTHi LOS-deficient mutants have been created and described. Strain 2019-DK1, an rfaD gene mutant, expresses a truncated LOS consisting of only three deoxy-D-manno-octulosonic acid residues, a single heptose, and lipid A. Strain 2019-B29, an isogenic htrB mutant, possesses an altered oligosaccharide core and an altered lipid A. Each strain's ability to colonize the nasopharynx and to induce OM subsequent to transbullar inoculation was evaluated in the chinchilla model. Nasopharyngeal colonization data indicate that the parent strain and both mutants are able to colonize the nasopharynx and exhibit comparable clearance kinetics. Compared with the parent and each other, however, the mutants demonstrated marked differences in virulence regarding their relative abilities to induce OM and persist in the middle ear post-transbullar inoculation. Strain B29 required a 3-log-greater dose to induce OM than the parent strain and did not exhibit evidence of sustained multiplication but persisted for the same duration as the parent. Conversely, strain-DK1, even when inoculated at a dose 4 logs greater than the parent dose, was eliminated from the middle ear 72 h after challenge. A comparison of the relative pathogenicities of these isolates provides the opportunity to address fundamental questions regarding the contribution of LOS to pathogenesis issues at the molecular level. Specifically, the impact of these LOS gene disruptions on OM pathogenesis can be defined and may thus provide potential new targets for future protection and intervention strategies.
大量证据表明,不可分型流感嗜血杆菌(NTHi)的脂寡糖(LOS)与中耳炎(OM)的发病机制有关;然而,其确切作用尚未最终确定。最近,已构建并描述了两种NTHi LOS缺陷型突变体。菌株2019-DK1是一种rfaD基因突变体,表达一种截短的LOS,仅由三个脱氧-D-甘露糖辛酮酸残基、一个庚糖和脂质A组成。菌株2019-B29是一种同基因htrB突变体,具有改变的寡糖核心和改变的脂质A。在豚鼠模型中评估了每种菌株在经鼓膜接种后定殖于鼻咽部并诱发中耳炎的能力。鼻咽部定殖数据表明,亲本菌株和两种突变体均能够定殖于鼻咽部,并表现出相似的清除动力学。然而,与亲本菌株以及彼此相比,这些突变体在经鼓膜接种后诱发中耳炎和在中耳持续存在的相对能力方面,毒力存在显著差异。菌株B29诱发中耳炎所需的剂量比亲本菌株高3个对数级,且未表现出持续增殖的迹象,但持续时间与亲本相同。相反,菌株DK1即使以比亲本剂量高4个对数级的剂量接种,在攻击后72小时也从中耳清除。对这些分离株相对致病性的比较提供了一个机会,以解决有关LOS在分子水平上对发病机制问题的贡献的基本问题。具体而言,可以确定这些LOS基因破坏对中耳炎发病机制的影响,从而可能为未来的保护和干预策略提供潜在的新靶点。